Moderna (MRNA) has its sights set on 2022 and beyond, even as it continues to produce doses for its COVID-19 vaccine this year.
CEO Stéphane Bancel told Yahoo Finance Wednesday that governments are now focused on booster shots for next year, even though it’s unclear what type of booster shot will be needed — or when it will be needed — as worries surface over emerging variants.
The pandemic still continues to claim casualties around the world, challenging efforts by the U.S., Britain…
Source link
